RECENT NEWS

Final HIV results of Ushercell Trials Presented at IAS Conference in Sydney

Gilead Grants Intellectual Property Rights For Tenofovir Topical Gel To The International Partnership For Microbicides And CONRAD

Update on lime juice as a microbicide in The Economist

Not-for-Profit Approach Improves Prospect of Vaccines and Drugs for the Poor.

Standardization of Colposcopy for the Evaluation of Vaginal Products

Microbicides 2008 Conference
February 24-27, 2008
New Delhi, India

PRESS RELEASES AND UPCOMING
                         MEETINGS

Reproductive Health 2007 Conference
September 26-29, 2007
Minneapolis, MN


American Public Health Association
Annual Meeting and Exposition
November 3-7, 2007
Washington, DC



Gates Foundation Give CONRAD $28.5M for Microbicide Research

CONRAD exists to facilitate the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections.

Our work does not begin in the laboratory or even in the scientist's mind, but with the needs of women and men everywhere who are struggling for a better life for themselves and their families. As a multifaceted organization involved in all aspects of product development, we place high priority on those needs, doing much of our work in real settings, with real people. Our broad scope, global network and focus on reproductive health enables us to help to ensure that the emerging and changing needs of women and men in under-resourced parts of the world are acted on in swift and prudent ways.

Read the entire letter from the Executive Director

-->